Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4045-4087
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4045
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4045
Type | Candidate marker |
Protein | LYVE1[334], REG1A[334], TTF1[334], TIMP1[335], MMP-2[335], NGAL[336], PGE2 metabolites[337], CD59 glycoprotein (CD59)[338], ANXA2[338], 21 kDA gelsolin fragment[338], S100A9[338] |
Liquid biopsy | UcfDNA: KRAS mutation[341]; Exosomal miRNA: miR-3940-5p[342], miR-8069[342] |
RNA | MiRNA: miR-143[340], miR-223[340], miR30e[340], miR-1246[18] |
Metallomics | Calcium[344], magnesium[344] |
Other | VOCs[343] |
- Citation: O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087
- URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4045.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4045